O'Neill Vincent
- SEC CIK
- 0001672718
No open-market purchases or sales filed in the past year.
Current role at each company
- BTAIQ BioXcel Therapeutics, Inc.Other: See Remarksas of Apr 1, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists O'Neill Vincent as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 (view filing)6:10 PM ET | Dec 16 | 1 day | O'Neill VincentSee Remarks | SSale | −165 | $0.3523 | −$58.13 | −0.8%20.0K after | 10b5-1 |
| Oct 3, 2024 (view filing) | Oct 3 | Same day | O'Neill VincentSee Remarks | SSale | −5.56K | $0.55 | −$3.06K | −22.1%19.6K after | 10b5-1 |
| Sep 17, 2024 (view filing) | Sep 16 | 1 day | O'Neill VincentSee Remarks | SSale | −138 | $0.69 | −$95.22 | −3.4%3.91K after | 10b5-1 |
| Jun 18, 2024 (view filing) | Jun 17 | 1 day | O'Neill VincentSee Remarks | SSale | −155 | $1.29 | −$199.95 | −4.2%3.52K after | 10b5-1 |
| Apr 8, 2024 (view filing) | Apr 4 | 4 days | O'Neill VincentSee Remarks | SSale | −165 | $2.62 | −$432.3 | −3.0%5.41K after | 10b5-1 |
| Mar 16, 2023 (view filing) | Mar 15 | 1 day | O'Neill VincentSee Remarks | SSale | −845 | $19.70 | −$16.6K | −40.5%1.24K after | From original |
| Jan 24, 2023 (view filing)8:04 PM ET | Jan 20 | 4 days | O'Neill VincentChief Medical Officer | SSale | −29.7K | $30.00 | −$891.4K | −100.0%0 after |